Sommadossi Jean-Pierre is a director of ABG Acquisition Corp I.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G/A
Atea Pharmaceuticals, Inc.
13 Feb 24
4
Atea Pharmaceuticals, Inc.
2 Feb 24
144
Atea Pharmaceuticals, Inc.
1 Feb 24
4
ABG Acquisition Corp. I
3 Mar 23
SC 13G/A
Atea Pharmaceuticals, Inc.
10 Feb 23
4
Atea Pharmaceuticals, Inc.
2 Feb 23
SC 13G/A
Atea Pharmaceuticals, Inc.
10 Feb 22
4
Atea Pharmaceuticals, Inc.
2 Feb 22
4
Kezar Life Sciences, Inc.
30 Jun 21
3
ABG Acquisition Corp. I
16 Feb 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Feb 24 | AVIR Atea Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 3.845 | 56,910 | 218.82 k | 116,557 |
31 Jan 24 | AVIR Atea Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 173,467 | 0.00 | 173,467 |
31 Jan 24 | AVIR Atea Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 4.16 | 448,000 | 1.86 mm | 448,000 |
31 Jan 24 | AVIR Atea Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 173,467 | 0.00 | 346,933 |
1 Mar 23 | ABGI ABG Acquisition Corp I | Class B ordinary shares Class A ordinary shares | Sale back to company | Dispose D | No | No | 0 | 32,500 | 0.00 | 0 |
31 Jan 23 | AVIR Atea Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 4.63 | 728,600 | 3.37 mm | 728,600 |
31 Jan 23 | AVIR Atea Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 520,400 | 0.00 | 520,400 |